Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 17.54% |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.66% |
| Mar 31, 2026 | 0.80% |
| Mar 31, 2025 | 72.17% |
| Dec 31, 2024 | -165.21% |
| Sep 30, 2024 | 157.19% |
| Jun 30, 2024 | 375.77% |
| Mar 31, 2024 | 232.52% |
| Dec 31, 2023 | 1.51% |
| Sep 30, 2023 | -12.87% |
| Jun 30, 2023 | 44.36% |
| Mar 31, 2023 | 34.94% |
| Mar 31, 2022 | -30.82% |
| Dec 31, 2021 | 67.98% |
| Sep 30, 2021 | -28.11% |
| Jun 30, 2021 | -26.25% |
| Mar 31, 2021 | -70.12% |
| Dec 31, 2020 | 39.87% |
| Sep 30, 2020 | 35.56% |
| Jun 30, 2020 | -46.29% |
| Mar 31, 2020 | -54.68% |